Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia

Luciana Teofili; Fiorina Giona; Maurizio Martini; Tonia Cenci; Francesco Guidi; Lorenza Torti; Giovanna Palumbo; Angela Amendola; Robin Foa; Luigi Maria Larocca

doi:10.1200/JCO.2006.08.6884

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia

Luciana Teofili, Fiorina Giona, Maurizio Martini, Tonia Cenci, Francesco Guidi, Lorenza Torti, Giovanna Palumbo, Angela Amendola, Robin Foa, Luigi Maria Larocca

Risultato della ricerca: Contributo in rivista › Articolo in rivista

82 Citazioni (Scopus)

Abstract

Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.

Lingua originale	English
pagine (da-a)	1048-1053
Numero di pagine	6
Rivista	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume	25
DOI	https://doi.org/10.1200/JCO.2006.08.6884
Stato di pubblicazione	Pubblicato - 2007

Keywords

Adolescent
Adult
Aged
Aged, 80 and over
Biological Markers
Child
Cohort Studies
Erythroid Precursor Cells
Female
Follow-Up Studies
GPI-Linked Proteins
Humans
Incidence
Isoantigens
Janus Kinase 2
Male
Membrane Glycoproteins
Middle Aged
Mutation
Myeloproliferative Disorders
Pedigree
Polycythemia Vera
RNA, Messenger
Receptors, Androgen
Receptors, Cell Surface
Receptors, Erythropoietin
Receptors, Thrombopoietin
Rome
Thrombocythemia, Essential
Thrombopoietin
Thrombosis
Time Factors

Accesso al documento

10.1200/JCO.2006.08.6884

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Teofili, L., Giona, F., Martini, M., Cenci, T., Guidi, F., Torti, L., Palumbo, G., Amendola, A., Foa, R., & Larocca, L. M. (2007). Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25, 1048-1053. https://doi.org/10.1200/JCO.2006.08.6884

@article{bb5f8b8927d0438583c224aac69a2438,

title = "Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia",

abstract = "Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.",

keywords = "Adolescent, Adult, Aged, Aged, 80 and over, Biological Markers, Child, Cohort Studies, Erythroid Precursor Cells, Female, Follow-Up Studies, GPI-Linked Proteins, Humans, Incidence, Isoantigens, Janus Kinase 2, Male, Membrane Glycoproteins, Middle Aged, Mutation, Myeloproliferative Disorders, Pedigree, Polycythemia Vera, RNA, Messenger, Receptors, Androgen, Receptors, Cell Surface, Receptors, Erythropoietin, Receptors, Thrombopoietin, Rome, Thrombocythemia, Essential, Thrombopoietin, Thrombosis, Time Factors, Adolescent, Adult, Aged, Aged, 80 and over, Biological Markers, Child, Cohort Studies, Erythroid Precursor Cells, Female, Follow-Up Studies, GPI-Linked Proteins, Humans, Incidence, Isoantigens, Janus Kinase 2, Male, Membrane Glycoproteins, Middle Aged, Mutation, Myeloproliferative Disorders, Pedigree, Polycythemia Vera, RNA, Messenger, Receptors, Androgen, Receptors, Cell Surface, Receptors, Erythropoietin, Receptors, Thrombopoietin, Rome, Thrombocythemia, Essential, Thrombopoietin, Thrombosis, Time Factors",

author = "Luciana Teofili and Fiorina Giona and Maurizio Martini and Tonia Cenci and Francesco Guidi and Lorenza Torti and Giovanna Palumbo and Angela Amendola and Robin Foa and Larocca, {Luigi Maria}",

year = "2007",

doi = "10.1200/JCO.2006.08.6884",

language = "English",

volume = "25",

pages = "1048--1053",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

}

Teofili, L, Giona, F, Martini, M, Cenci, T, Guidi, F, Torti, L, Palumbo, G, Amendola, A, Foa, R & Larocca, LM 2007, 'Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 25, pagg. 1048-1053. https://doi.org/10.1200/JCO.2006.08.6884

TY - JOUR

T1 - Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia

AU - Teofili, Luciana

AU - Giona, Fiorina

AU - Martini, Maurizio

AU - Cenci, Tonia

AU - Guidi, Francesco

AU - Torti, Lorenza

AU - Palumbo, Giovanna

AU - Amendola, Angela

AU - Foa, Robin

AU - Larocca, Luigi Maria

PY - 2007

Y1 - 2007

N2 - Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.

AB - Polycythemia vera (PV) and essential thrombocythemia (ET) can present in pediatric age as sporadic or familial diseases. To define the biologic profile of childhood PV and ET, we evaluated specific markers in a cohort of pediatric patients affected by PV and ET, including cases with familial occurrence.

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Biological Markers

KW - Child

KW - Cohort Studies

KW - Erythroid Precursor Cells

KW - Female

KW - Follow-Up Studies

KW - GPI-Linked Proteins

KW - Humans

KW - Incidence

KW - Isoantigens

KW - Janus Kinase 2

KW - Male

KW - Membrane Glycoproteins

KW - Middle Aged

KW - Mutation

KW - Myeloproliferative Disorders

KW - Pedigree

KW - Polycythemia Vera

KW - RNA, Messenger

KW - Receptors, Androgen

KW - Receptors, Cell Surface

KW - Receptors, Erythropoietin

KW - Receptors, Thrombopoietin

KW - Rome

KW - Thrombocythemia, Essential

KW - Thrombopoietin

KW - Thrombosis

KW - Time Factors

KW - Adolescent

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Biological Markers

KW - Child

KW - Cohort Studies

KW - Erythroid Precursor Cells

KW - Female

KW - Follow-Up Studies

KW - GPI-Linked Proteins

KW - Humans

KW - Incidence

KW - Isoantigens

KW - Janus Kinase 2

KW - Male

KW - Membrane Glycoproteins

KW - Middle Aged

KW - Mutation

KW - Myeloproliferative Disorders

KW - Pedigree

KW - Polycythemia Vera

KW - RNA, Messenger

KW - Receptors, Androgen

KW - Receptors, Cell Surface

KW - Receptors, Erythropoietin

KW - Receptors, Thrombopoietin

KW - Rome

KW - Thrombocythemia, Essential

KW - Thrombopoietin

KW - Thrombosis

KW - Time Factors

UR - http://hdl.handle.net/10807/26209

U2 - 10.1200/JCO.2006.08.6884

DO - 10.1200/JCO.2006.08.6884

M3 - Article

VL - 25

SP - 1048

EP - 1053

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ER -

Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo